Foldax, Inc.

SALT LAKE CITY, UT · Founded 2013 · Medtech · Private

Implantable tricuspid heart valve with tissue-engineered design

Claim this profile

Follows are private to you and power your alerts

Updated · foldax.com

Sector
Medtech
Headquarters
SALT LAKE CITY, UT
Founded
2013
Latest Form D
$7M, Nov 2023
Total capital
$23.7M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$23.7M
10 Form D · last Nov 2023
36 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
8
15 pending · first 2016
Rank in peer group#229 of 1112

Capital timeline

20142016201820202022FEDERAL ↑EQUITY ↓Cumulative $38.7M8th Form D$10.3M9th Form D$15M
20142016201820202022FEDERAL ↑EQUITY ↓Cumulative $38.7M9th Form D$15M

Latest events

  • Private capital raisedForm D · SEC · 10th filing$7M
  • Offering registeredForm D · SEC · 9th filing$15M
  • Private capital raisedForm D · SEC · 8th filing$10.3M
  • Private capital raisedForm D · SEC · 7th filing$300K
  • Private capital raisedForm D · SEC · 6th filing$3.1M
  • Private capital raisedForm D · SEC · 5th filing$2.5M
  • Private capital raisedForm D · SEC · 4th filing$350K
  • Private capital raisedForm D · SEC · 3rd filing$50K
  • Private capital raisedForm D · SEC · 2nd filing$150K
  • Private capital raisedForm D · SEC · 1st filing$15K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#229 · top 21%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Brant HeiseDirectorNamed in SEC Form D filings
  • Demetriades JamesDirectorNamed in SEC Form D filings
  • Frank MaguireExecutive Officer, DirectorNamed in SEC Form D filings
  • George WallaceDirectorNamed in SEC Form D filings
  • Greg CasciaroExecutive Officer, DirectorNamed in SEC Form D filings
  • James DemetriadesDirectorNamed in SEC Form D filings
Show all 14 people
  • Jim DemetriadesDirectorNamed in SEC Form D filings
  • Ken CharhutDirectorNamed in SEC Form D filings
  • Kenneth CharhutDirectorNamed in SEC Form D filings
  • Morteza GharibDirectorNamed in SEC Form D filings
  • Mory GharibDirectorNamed in SEC Form D filings
  • Renee MasiDirectorNamed in SEC Form D filings
  • Scott HuennekensDirectorNamed in SEC Form D filings
  • Scott RichlandDirectorNamed in SEC Form D filings

What it has protected

USPTO · 8 granted of 23
  • PendingTranscatheter Valve Introducer System And MethodsUSPTOApplication 18835852
  • PendingPolyurethane/urea MaterialsUSPTOApplication 18668972
  • GrantedPolyurethane/urea MaterialsUSPTOUS 12,129,331
Show all 23 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .